Industries

You dispense today. Reimbursement takes its time.

Pharmacies carry the cost of stock and staff while reimbursements work their way through the system. One request compares funding for the gap, the seasonal stock-up or the next branch, with a soft check that leaves no trace on your credit file.

Soft check · no impact on your credit score.2

  • 5 to 6 figures4typical funding range
  • Soft check2no credit-score impact
  • ~24 hours3from match to funded
  • One requesta whole lender network

How it works

1

Tell us what you need

Answer a few questions about your business and how much funding you’re after. It takes about 60 seconds.

2

Compare your matched offers

We match you with funding partners and bring back competing offers, a soft search with no impact on your credit score.

3

Get funded

Pick the offer that fits and get the funds in your account, often within a few business days.

01

How funding works

Pharmacy cash flow runs on a delay you do not control. You dispense an NHS prescription today, pay your wholesaler for the stock on weekly or monthly account terms, then wait for the NHS Business Services Authority to reimburse you, usually around a month after you submit the claim and roughly six to eight weeks after you actually handed the medicine over. Add Category M margin adjustments, clawbacks and the odd high-cost item or special, and a busy dispensing month can tie up far more working capital than the till suggests.

Capvant is a funding marketplace, not a lender. We match UK limited companies, LLPs and plcs that run pharmacies with a network of vetted funding partners who then compete for your business, so you can line up the reimbursement gap against the right product instead of taking the first offer your bank shows you. Comparing options is a soft search with no impact on your credit score; a hard check only happens if you accept an offer.

02

Products that fit

Most pharmacies do not need one big loan. They need the right mix: something to smooth the NHS reimbursement lag, a buffer for heavy stock months, and longer money for a robot, a refit or buying a second branch. Because Capvant's partners compete, you can compare these side by side rather than forcing one product to do every job.

Here is how the main options tend to map to a pharmacy.

Working capitalbridge the gap between dispensing and NHS reimbursement, and pay wholesaler accounts on time without draining your reserves.
Business line of credita revolving buffer you draw on only when a high-cost dispensing month or a slow week hits, then repay and reuse.
Term loanlonger, structured funding for buying a pharmacy, acquiring goodwill or a second branch, or a full premises refurbishment.
Equipment financespread the cost of a dispensing robot, an EPOS and PMR system, fridges or a new consultation room over its working life.
Revenue Advancea lump sum repaid as an agreed share of your card and dispensing income, so repayments flex down when takings are quieter.
Invoice financerelease cash tied up in B2B invoices, for example supplying dosette trays to care homes or private prescription work, rather than waiting on payment terms.
03

Seasonal cash flow

Pharmacy demand is not flat across the year. From September you are buying flu and, increasingly, COVID and RSV vaccine stock upfront before a single jab is paid for, and winter pushes prescription volumes, OTC cough and cold sales and minor illness consultations to their annual high. Spring and high summer are usually quieter on dispensing, even as the front shop ticks along.

That rhythm is exactly why a short-term facility or a line of credit can pay for itself. Funding the autumn vaccine buy-in or the winter stock build means you capture the seasonal income rather than rationing orders, and a flexible product lets you draw when you need it and repay as the NHS settlements and vaccination fees come through.

04

What lenders look at

The good news is that a pharmacy is a lender-friendly business. Your core income is recurring and largely government-backed, so funding partners pay close attention to your NHS dispensing volumes and FP34 reimbursement schedules, your contract type, and any advanced services income from Pharmacy First, the New Medicine Service, flu jabs and blood pressure checks. Steady scripts per month reassure a partner far more than a single strong quarter.

They will also look at how you run the wider business: your wholesaler account conduct and terms, front-of-shop and OTC turnover, your card takings, and how clean your bank account and filed accounts look. If you are buying a pharmacy, the goodwill value usually tracks dispensing volume and the NHS contract, so expect partners to weigh the branch's script numbers heavily.

05

Where the money goes

Acquisition is the big one. Pharmacies change hands on goodwill multiples, and buying your first branch or adding a second almost always needs structured term funding alongside your deposit. Beyond that, owners borrow to invest in productivity: a dispensing robot to free up pharmacist time, an upgraded PMR and EPOS system, or building out a private consultation room so you can deliver and bill more Pharmacy First and private services.

Just as often it is about smoothing the everyday. A single month of high-cost specials, a large care-home dispensing contract, a VAT or tax bill landing at the wrong moment, or simply the constant lag between dispensing and reimbursement can all justify a working capital facility. The point of comparing is to match the length of the money to the job: short facilities for cash-flow timing, longer term loans for assets and acquisitions.

06

Comparing your offers

You can prepare in an afternoon. Have your recent business bank statements, filed or management accounts, a sense of your monthly NHS dispensing income and FP34 schedules, and a clear figure for what you want to fund and why. If it is an acquisition, the target's dispensing data and the heads of terms will speed everything up. The clearer the picture, the keener the offers tend to be.

Capvant then lets you compare those offers in one place, with the rates, terms and repayment shapes side by side, so you can favour the structure that suits a pharmacy's reimbursement rhythm rather than the first quote you are given. Remember that Capvant is a marketplace of competing funding partners, not a lender, and funding is for business purposes only. Comparing is a soft search with no impact on your credit score, and a hard check only happens if you accept an offer.

Pharmacies funding, your questions

Can my pharmacies business get funding through Capvant?

Yes. Capvant works with funding partners that fund pharmacies businesses across the United States. One request matches you with the partners most likely to say yes.

What funding suits pharmacies businesses?

It depends on your goal, common options include working capital, business line of credit, business term loan, equipment financing, revenue advance. Compare them side by side and pick what fits.

Will checking my options affect my credit score?

No. Seeing your options through Capvant is a soft search, so it leaves no mark on your credit file. A lender only runs a full credit check if you decide to accept an offer.

Is Capvant a lender?

No. Capvant is a funding marketplace, we match you with funding partners and you choose the offer that suits you. Funding decisions, rates and terms are set by the lender, subject to approval.

How fast can I get funded?

Once you accept an offer, many businesses receive funds within a few business days, some products fund same day.

Fund your pharmacies business

Compare offers from funding partners in minutes, no obligation, no credit-score impact.

Soft check · no impact on your credit score.2

Disclaimers & footnotes

  1. 1Capvant is a funding marketplace, not a lender. We match business owners with third-party funding partners; we do not make credit decisions, lend money, or set rates or terms. All funding decisions, rates, terms and approvals are made solely by the lenders in our network, subject to their criteria.
  2. 2Checking your options through Capvant does not affect your credit score. A lender may carry out a soft or hard credit search depending on the product, stage and your consent. A full hard credit check is only carried out where required by a lender before you proceed.
  3. 3Funding speed, including any reference to funding in as little as 24 hours, is typical for some products and lenders and is not guaranteed. Actual timescales depend on the lender, the product, and how quickly requested information and documents are provided.
  4. 4Funding amounts and ranges are indicative only and vary with your business profile, trading history, the lender and the market. Figures shown are not an offer of finance and do not guarantee any particular amount, rate or approval.
  5. 5Any offers, rates or repayment figures shown in illustrations or examples are for demonstration only and are not real quotes. Your actual offers, if any, are provided by lenders and are subject to approval.
  6. 6Product availability varies by market. Some products are only available in certain countries. Capvant currently serves businesses in the United States and the United Kingdom.

Capvant is a trading name of Granton Hale Capital LLC. Capvant is not a lender and does not make credit decisions, we introduce businesses to third-party funding providers. Capvant is not authorised or regulated by the Financial Conduct Authority (FCA).

Capvant does not compare every lender, broker, funding product or offer available in the market. We only show options from funding partners in our network that may be relevant based on the information you provide.

Capvant may receive compensation from lenders, brokers, funding partners or referral partners when a customer is introduced, approved, funded or takes another qualifying action. This compensation does not guarantee that any lender will approve an application or offer specific terms. Capvant does not charge business owners a fee to compare funding options unless clearly stated otherwise.

If you access Capvant through a partner, introducer or embedded funding page, that partner may receive a referral fee or commission if your application results in funding. This does not increase your cost unless expressly disclosed.

Capvant is intended for business-purpose funding only. Eligibility may depend on entity type, location, trading history, revenue, industry and lender criteria. In the UK, Capvant currently focuses on limited companies, LLPs and plcs, and does not currently support sole traders or ordinary partnerships.

Information on Capvant is general information only and is not financial, legal, tax or accounting advice. You should consider whether funding is suitable for your business and seek professional advice where appropriate.

Calculators, eligibility checkers and funding-readiness tools are estimates only. They are based on limited information and assumptions, and do not represent a credit decision, quote, approval or recommendation.

Company information may be sourced from public registers such as Companies House, or from information you provide. Public register data may be incomplete, delayed or inaccurate and should not be treated as a full credit assessment.

By submitting an application or funding request, you authorise Capvant to share relevant business, owner, application and document information with funding partners, service providers and introducers where necessary to process your request, subject to our Privacy Policy.

Some US commercial financing offers may be subject to state-specific disclosure requirements. Where required, additional disclosures will be provided and must be accepted before a transaction is finalised.